Drug-drug interaction between diltiazem and tacrolimus in relation to CYP3A5 genotype status in Chinese pediatric patients with nephrotic range proteinuria: a retrospective study

• Qiaoling Yang,
• Qiaoling Yang,
• Yan Wang,
• Yan Wang,
• Xuebin Wang,
• Ping Wang,
• Boyu Tan,
• Yijun Li,
• Huajun Sun,
• Wenyan Huang,
• Hongxia Liu

Affiliations

Qiaoling Yang

Department of Pharmacy, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Qiaoling Yang

Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Yan Wang

Department of Pharmacy, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Yan Wang

Department of Pharmacy, Clinical Medical College, Affiliated Hospital of Chengdu University, Chengdu, China

Xuebin Wang

Department of Pharmacy, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Ping Wang

Department of Nephrology and Rheumatology, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Boyu Tan

Department of Pharmacy, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Yijun Li

Department of Pharmacy, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Huajun Sun

Department of Pharmacy, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Wenyan Huang

Department of Nephrology and Rheumatology, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Hongxia Liu

Department of Pharmacy, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China